Vertex, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $VERX in the last 30 days.
See all $VERX insider activity →Vertex Inc. (VERX) appointed Debanjan Saha as a Class II director, effective October 7, 2026. Saha is the CEO of DataRobot and has prior roles at Google Cloud and AWS. The appointment follows a recommendation by the Nominating and Governance Committee.
Vertex, Inc. (VERX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 30, 2026, the Board of Directors (the “Board”) of Vertex, Inc. (the “Company”), upon the recommendation of th
Vertex, Inc. (VERX) shares rose about 6.5% after it reported Q2 revenue of $203.97 million and returned to quarterly profitability. The company updated 2026 guidance and named three senior leaders, including Bala Chandran as Chief Product and Technology Officer, to support SaaS and AI initiatives and international expansion.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning VERX (Vertex, Inc.). Coverage has been balanced: 0 bullish, 2 neutral, and 0 bearish.
Recent VERX coverage spans earnings, financial news and corporate actions.
Board appointment with no immediate financial impact.
Director appointment adds experienced AI leadership but has limited immediate market impact.
The article frames a near-term earnings and guidance reset plus AI/product leadership hires, which can support a positive re-rating if execution follows.
The article frames VERX as potentially undervalued after Q2 results and guidance, but it provides no specific guidance numbers beyond the fair-value narrative.
Raised profitability guidance alongside slower cloud conversion timing suggests near-term revenue timing risk but improving margin durability.
AlphAI scores every news story that mentions VERX with an AI model for sentiment and relevance, and aggregates insider trades from Vertex, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Vertex Inc. (VERX) appointed Debanjan Saha as a Class II director, effective October 7, 2026. Saha is the CEO of DataRobot and has prior roles at Google Cloud and AWS. The appointment follows a recommendation by the Nominating and Governance Committee.
1 min readVertex, Inc. (VERX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 30, 2026, the Board of Directors (the “Board”) of Vertex, Inc. (the “Company”), upon the recommendation of th
1 min readVertex, Inc. (VERX) shares rose about 6.5% after it reported Q2 revenue of $203.97 million and returned to quarterly profitability. The company updated 2026 guidance and named three senior leaders, including Bala Chandran as Chief Product and Technology Officer, to support SaaS and AI initiatives and international expansion.
6 min readSimply Wall St reports Vertex (VERX) posted Q2 2026 revenue of $203.97 million and positive net income, updated revenue guidance, and appointed three senior leaders. The article cites a fair value of $18.54 versus a $13.26 latest close, implying 29% undervaluation, and links upside to European e-invoicing mandates in 2026-2027.
5 min readVertex, Inc. (VERX) reported Q2 2026 revenue of $204 million, up 10.5% year over year and at the high end of guidance. Adjusted EBITDA rose 33% to $51 million, with margin expanding to 25.0%. Subscription revenue grew to $174.8 million and ARR reached $703.4 million. Full-year revenue guidance was narrowed to $825-$830 million and adjusted EBITDA guidance raised to $206-$210 million.
6 min readVertex (NASDAQ: VERX) raised its 2026 adjusted EBITDA outlook to $206M-$210M after Q2 revenue rose 10.5% to $204M and cloud revenue grew 17.9% to $101.7M. Full-year revenue guidance was narrowed to $825M-$830M, with 18% cloud growth expected. Q2 adjusted EBITDA rose 32.8% to $51M.
4 min readVertex (NASDAQ:VERX) said slower cloud conversion is a timing issue, with customers using mixed cloud and on-prem deployments. Management highlighted strong e-invoicing momentum ahead of France and Germany mandates, expecting e-invoicing to affect ARR in Q3 and more in Q4. Q3 guidance: revenue $208M-$211M, adj. EBITDA $55M-$57M; full-year revenue $825M-$830M and adj. EBITDA $206M-$210M.
6 min readSimply Wall St reports Vertex (VERX) shares fell about 8% to $12.39 after Q2 results. Revenue rose to about $204m and the company swung to profit, with basic EPS of $0.06 and adjusted EBITDA of $51m (25% margin). Cloud and e-invoicing growth guidance and execution concerns left investors divided.
4 min readVertex Pharmaceuticals shares fell 12.8% after its post-close Q2 2026 results. The company reported EPS of $0.20 vs $0.19 consensus and revenue of $203.97M vs $202.29M forecast, but Q3 2026 revenue guidance of $208M-$211M (midpoint below ~$211.69M consensus) and free cash flow of $2.7M disappointed. Morgan Stanley downgraded to Equal Weight and cut its price target to $15 from $19.
4 min readVertex Inc. (NASDAQ:VERX) shares dropped 13.2% after its Q2 results missed cloud growth expectations and analysts cut price targets. DA Davidson lowered its target to $12 from $15, citing slower cloud conversions and reduced FY26 cloud growth guidance to 18% from 25%. Other analysts also adjusted targets following guidance and deal-cycle comments.
3 min read
